Cargando…
Coronavirus Disease-2019 in the Immunocompromised Host
Immunocompromised hosts, which encompass a diverse population of persons with malignancies, human immunodeficiency virus disease, solid organ, and hematologic transplants, autoimmune diseases, and primary immunodeficiencies, bear a significant burden of the morbidity and mortality due to coronavirus...
Autores principales: | Bertini, Christopher D., Khawaja, Fareed, Sheshadri, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678818/ https://www.ncbi.nlm.nih.gov/pubmed/37085228 http://dx.doi.org/10.1016/j.ccm.2022.11.012 |
Ejemplares similares
-
Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
por: Haidar, Ghady, et al.
Publicado: (2021) -
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023) -
Sepsis in Immunocompromised Hosts
por: Conlon, Christopher
Publicado: (2000) -
Infections in the Immunocompromised Host
por: Bin-Hussain, Ibrahim
Publicado: (2012) -
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
por: Haidar, Ghady, et al.
Publicado: (2023)